284 related articles for article (PubMed ID: 32270250)
21. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
[TBL] [Abstract][Full Text] [Related]
22. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.
Kim HJ; McCoy MR; Majkova Z; Dechant JE; Gee SJ; Tabares-da Rosa S; González-Sapienza GG; Hammock BD
Anal Chem; 2012 Jan; 84(2):1165-71. PubMed ID: 22148739
[TBL] [Abstract][Full Text] [Related]
23. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
[TBL] [Abstract][Full Text] [Related]
24. NanoPad: an integrated platform for bacterial production of camel nanobodies aimed at detecting environmental biomarkers.
Fraile S; Jiménez JI; Gutiérrez C; de Lorenzo V
Proteomics; 2013 Oct; 13(18-19):2766-75. PubMed ID: 23661305
[TBL] [Abstract][Full Text] [Related]
25. Surface display of a single-domain antibody library on Gram-positive bacteria.
Fleetwood F; Devoogdt N; Pellis M; Wernery U; Muyldermans S; Ståhl S; Löfblom J
Cell Mol Life Sci; 2013 Mar; 70(6):1081-93. PubMed ID: 23064703
[TBL] [Abstract][Full Text] [Related]
26. Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.
Ryckaert S; Pardon E; Steyaert J; Callewaert N
J Biotechnol; 2010 Jan; 145(2):93-8. PubMed ID: 19861136
[TBL] [Abstract][Full Text] [Related]
27. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
Ji L; Dong C; Fan R; Qi S
Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
[TBL] [Abstract][Full Text] [Related]
28. [Screening and activity analysis of nanobodies against lymphocyte activation gene-3(LAG-3)].
Wen R; Chen Y; Yang Z; Yan F; Li Q; Wu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):1024-1031. PubMed ID: 37980554
[TBL] [Abstract][Full Text] [Related]
29. Characterization of nanobodies binding human fibrinogen selected by E. coli display.
Salema V; López-Guajardo A; Gutierrez C; Mencía M; Fernández LÁ
J Biotechnol; 2016 Sep; 234():58-65. PubMed ID: 27485813
[TBL] [Abstract][Full Text] [Related]
30. Anti-idiotypic nanobody as citrinin mimotope from a naive alpaca heavy chain single domain antibody library.
Xu Y; Xiong L; Li Y; Xiong Y; Tu Z; Fu J; Chen B
Anal Bioanal Chem; 2015 Jul; 407(18):5333-41. PubMed ID: 25910884
[TBL] [Abstract][Full Text] [Related]
31. Nanobody-based enzyme immunoassay for aflatoxin in agro-products with high tolerance to cosolvent methanol.
He T; Wang Y; Li P; Zhang Q; Lei J; Zhang Z; Ding X; Zhou H; Zhang W
Anal Chem; 2014 Sep; 86(17):8873-80. PubMed ID: 25079057
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Three Antihapten VHH Selection Strategies for the Development of Highly Sensitive Immunoassays for Microcystins.
Pírez-Schirmer M; Rossotti M; Badagian N; Leizagoyen C; Brena BM; González-Sapienza G
Anal Chem; 2017 Jun; 89(12):6800-6806. PubMed ID: 28494149
[TBL] [Abstract][Full Text] [Related]
33. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
Ferrari D; Garrapa V; Locatelli M; Bolchi A
Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
[TBL] [Abstract][Full Text] [Related]
34. Single-domain antibodies and their utility.
Baral TN; MacKenzie R; Arbabi Ghahroudi M
Curr Protoc Immunol; 2013 Nov; 103():2.17.1-2.17.57. PubMed ID: 24510545
[TBL] [Abstract][Full Text] [Related]
35. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
[TBL] [Abstract][Full Text] [Related]
36. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging.
Li T; Bourgeois JP; Celli S; Glacial F; Le Sourd AM; Mecheri S; Weksler B; Romero I; Couraud PO; Rougeon F; Lafaye P
FASEB J; 2012 Oct; 26(10):3969-79. PubMed ID: 22730440
[TBL] [Abstract][Full Text] [Related]
37. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
[TBL] [Abstract][Full Text] [Related]
38. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
[TBL] [Abstract][Full Text] [Related]
39. Structure- and sequence-based design of synthetic single-domain antibody libraries.
Sevy AM; Chen MT; Castor M; Sylvia T; Krishnamurthy H; Ishchenko A; Hsieh CM
Protein Eng Des Sel; 2020 Sep; 33():. PubMed ID: 33341882
[TBL] [Abstract][Full Text] [Related]
40. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
Gavira-O'Neill CE; Dong JX; Trimmer JS
Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
